| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥138.0B | ¥124.2B | +11.1% |
| Operating Income | ¥5.4B | ¥4.7B | +14.4% |
| Ordinary Income | ¥6.5B | ¥7.3B | -11.1% |
| Net Income | ¥4.4B | ¥5.3B | -17.0% |
| ROE | 2.7% | 3.4% | - |
FY2025 Q3 cumulative results showed revenue of 13.80 billion yen (YoY +11.1%), operating income of 540 million yen (+14.4%), ordinary income of 648 million yen (-11.1%), and net income of 437 million yen (-17.0%). The company achieved top-line growth and operating profit improvement, though bottom-line profitability declined. Total assets increased to 226.3 billion yen from 220.4 billion yen, while equity strengthened to 161.6 billion yen from 156.1 billion yen, maintaining a conservative balance sheet structure. The divergence between operating profit growth and net income decline reflects non-operating factors including foreign exchange losses of 30 million yen offsetting operating improvements.
Revenue increased 1.38 billion yen YoY, representing an 11.1% growth rate that outpaced the industry median of 2.7% for manufacturing sector. This top-line expansion was driven by core precision parts manufacturing and unit processing business operations. Gross profit reached 1.66 billion yen with a gross margin of 12.0%, which remains below industry benchmarks and indicates pricing pressure or product mix challenges. Operating income improved 14.4% YoY to 540 million yen, though the operating margin of 3.9% remains constrained and below the 5% threshold. Selling, general and administrative expenses totaled 1.12 billion yen, with improved operating leverage contributing to the margin expansion from revenue growth. The gap between ordinary income and operating income widened negatively, with ordinary income declining 11.1% despite operating profit gains. This was primarily caused by foreign exchange losses of 30 million yen recorded in non-operating expenses, partially offset by non-operating income of 143 million yen including interest income. Net income decreased 17.0% to 437 million yen, with an effective tax rate of approximately 32.3% within normal ranges. The performance pattern represents revenue up/profit down at the bottom line, driven by non-operating headwinds overwhelming operating improvements.
[Profitability] ROE of 2.7% based on DuPont decomposition (net margin 3.2% × asset turnover 0.61 × financial leverage 1.40) represents deterioration in capital efficiency, falling below the company's sustainable level and significantly underperforming the industry median of 5.0%. Operating margin of 3.9% expanded from prior year's 3.8% by 0.1pt but remains well below the industry median of 8.3%, indicating structural profitability challenges. Net profit margin of 3.2% compressed from prior year's 4.3%, underperforming the industry median of 6.3% and reflecting margin pressure. Gross profit margin of 12.0% remains low compared to typical manufacturing benchmarks of 20% or higher, suggesting limited pricing power or high manufacturing overhead. Return on assets of 1.9% (annualized from quarterly net income) falls below the industry median of 3.3%, confirming weak asset productivity. [Cash Quality] Cash and deposits of 4.50 billion yen provide coverage of 8.3 times against short-term liabilities, indicating strong liquidity buffer. Working capital of 9.63 billion yen reflects ample operational cushion, though efficiency metrics show deterioration. Days sales outstanding extended to 138 days, significantly exceeding the industry median of 83 days and indicating collection challenges. Cash conversion cycle lengthened to 147 days, above the industry median of 108 days, reflecting working capital inefficiency. [Investment Efficiency] Asset turnover of 0.61 aligns with the industry median of 0.58, showing comparable asset utilization efficiency. Investment securities increased 811 million yen or 63.5% YoY to 2.09 billion yen, representing a substantial portfolio expansion that may introduce valuation volatility. Work-in-process inventory of 1.68 billion yen accounts for 66.9% of total inventory, suggesting extended manufacturing cycles or process bottlenecks. Return on invested capital remains constrained by low operating margins despite moderate leverage deployment. [Financial Health] Equity ratio of 71.4% improved from 70.8% YoY, exceeding the industry median of 63.8% and confirming conservative capitalization. Current ratio of 277.4% substantially exceeds the industry median of 284%, providing robust short-term solvency. Debt-to-equity ratio of 0.40 reflects minimal leverage usage and strong balance sheet protection. Total liabilities of 6.48 billion yen represent only 28.6% of total assets, indicating low financial risk exposure.
Cash and deposits increased 146 million yen YoY to 4.50 billion yen, reflecting modest cash accumulation despite net income generation of 437 million yen in the nine-month period. The cash growth rate of 3.4% lagged behind net income as a percentage of beginning cash, suggesting working capital absorption of operating cash generation. Accounts receivable increased to 5.23 billion yen with electronically recorded receivables at 1.70 billion yen, representing combined growth in credit sales that extended collection cycles to 138 days and consumed operating cash. Work-in-process inventory of 1.68 billion yen indicates production cycle extension that ties up capital in manufacturing processes. Accounts payable and other current liabilities provide supplier credit utilization, though payables turnover data indicates opportunities for working capital optimization. Investment securities expanded 811 million yen, representing a substantial investing cash outflow for portfolio acquisition or fair value increases. The cash coverage ratio of 8.3 times against short-term liabilities confirms adequate liquidity positioning despite working capital headwinds. Total assets increased 5.93 billion yen to 226.3 billion yen, with the growth funded by retained earnings accumulation and maintained equity buildup, sustaining the conservative 71.4% equity ratio without material debt increases.
Ordinary income of 648 million yen versus operating income of 540 million yen shows net non-operating contribution of approximately 108 million yen, comprising primarily interest and dividend income from the expanded investment securities portfolio alongside foreign exchange impacts. Non-operating income totaled 143 million yen representing 1.0% of revenue, consisting of financial income as the primary component with interest and dividends contributing positively from the 2.09 billion yen investment portfolio. Non-operating expenses of 35 million yen included foreign exchange losses of 30 million yen, introducing earnings volatility from currency fluctuations that impacted the ordinary income comparison. The operating profit represents core business profitability excluding financial and investment factors, though the 3.9% margin indicates limited pricing power and cost structure challenges. The material gap between ordinary income decline of 11.1% and operating income growth of 14.4% highlights the significant role of non-recurring or volatile non-operating items. Cash flow statement data is unavailable for quarterly reporting, preventing direct assessment of operating cash flow versus net income for accruals analysis. Working capital metrics show deterioration with extended DSO of 138 days and elevated work-in-process inventory suggesting potential accruals buildup, though this cannot be definitively confirmed without operating cash flow disclosure. The investment securities fair value changes may introduce unrealized gains or losses affecting comprehensive income beyond reported net income, representing a quality consideration for sustainability assessment.
Full-year guidance projects revenue of 17.80 billion yen, operating income of 580 million yen, ordinary income of 690 million yen, and net income of 480 million yen. Q3 cumulative progress rates versus full-year targets stand at revenue 77.5%, operating income 93.1%, ordinary income 93.9%, and net income 91.0%. Revenue progress of 77.5% exceeds the standard Q3 rate of 75%, indicating slight ahead-of-schedule top-line performance. Operating income progress of 93.1% significantly exceeds the 75% standard, suggesting conservative full-year guidance or front-loaded profitability with potential Q4 deceleration. Ordinary income progress of 93.9% similarly exceeds standard progression, though the forecast implies 15.4% YoY decline for the full year compared to prior year. Net income progress of 91.0% indicates most annual earnings have been recognized through Q3, with the full-year forecast representing 17.0% YoY decline. The guidance assumes ordinary income decline of 15.4% YoY despite operating income growth of 6.2% YoY, reflecting anticipated non-operating headwinds including foreign exchange impacts. Dividend per share is maintained at 20 yen for the full year, unchanged from prior guidance, with forecast EPS of 54.09 yen implying a payout ratio of approximately 37.0% on full-year basis.
Annual dividend of 20 yen per share is projected for the full year, unchanged from prior year levels, representing stable dividend maintenance despite net income decline. The payout ratio based on Q3 cumulative net income and annualized dividend stands at approximately 41.2%, calculated as 20 yen times 9.00 million shares divided by 437 million yen net income. Full-year forecast payout ratio of 37.0% based on projected net income of 480 million yen indicates sustainable dividend coverage within typical 30-50% target ranges. No share buyback activity has been disclosed in the current period. Total shareholder return consists solely of dividend distributions without capital returns through repurchases. The dividend policy maintains consistency despite earnings volatility, supported by the strong equity base of 161.6 billion yen and equity ratio of 71.4% providing financial flexibility for dividend sustainability.
Operating margin compression risk remains elevated with 3.9% EBIT margin well below 5% threshold and industry median of 8.3%, indicating vulnerability to cost inflation or pricing pressure that could eliminate profitability. Gross margin of 12.0% provides limited buffer against raw material cost increases or competitive pricing dynamics, with each 1pt margin decline representing approximately 138 million yen annual profit impact. Working capital deterioration poses liquidity risk with DSO extending to 138 days versus industry median of 83 days, representing 6.33 billion yen tied up in receivables and creating potential cash flow strain if collection delays persist. Work-in-process inventory at 1.68 billion yen or 66.9% of total inventory indicates production process bottlenecks or extended manufacturing cycles that increase carrying costs, quality risks, and working capital requirements beyond industry norms. Foreign exchange volatility presents earnings risk as evidenced by 30 million yen FX loss in Q3, with ordinary income showing 11.1% decline despite operating profit growth, suggesting material exposure to currency fluctuations without disclosed hedging programs.
[Industry Position] (Reference - Proprietary Analysis) Profitability: ROE of 2.7% substantially underperforms the manufacturing industry median of 5.0% and falls below the interquartile range of 2.9-8.1%, positioning the company in the lower quartile for capital efficiency. Operating margin of 3.9% significantly trails the industry median of 8.3% (IQR: 4.8-12.6%), indicating structural profitability challenges requiring margin improvement initiatives. Net profit margin of 3.2% underperforms the industry median of 6.3% (IQR: 3.2-9.0%), though meets the lower bound of typical ranges. Financial Health: Equity ratio of 71.4% exceeds the industry median of 63.8% (IQR: 49.5-74.7%), reflecting conservative capitalization that provides financial stability but may indicate underutilization of leverage for growth. Current ratio of 277.4% aligns closely with industry median of 284% (IQR: 210-381%), confirming adequate liquidity positioning comparable to sector peers. Efficiency: Asset turnover of 0.61 matches the industry median of 0.58 (IQR: 0.42-0.66), showing comparable asset utilization despite profitability gaps. Receivables turnover of 138 days substantially exceeds the industry median of 83 days (IQR: 68-115 days), highlighting collection efficiency as a competitive disadvantage requiring working capital management focus. Inventory turnover positioning shows elevated work-in-process concentration compared to typical manufacturing inventory structures. Growth: Revenue growth of 11.1% YoY significantly outperforms the industry median of 2.7% (IQR: -1.9% to 7.9%), positioning in the upper quartile for top-line expansion and demonstrating market share gains or end-market strength. ※ Industry: Manufacturing (98 companies), Comparison: FY2025 Q3 period, Source: Proprietary analysis
Revenue growth momentum of 11.1% substantially outpacing industry median of 2.7% demonstrates strong market positioning and demand capture, with Q3 progress rate of 77.5% versus full-year guidance indicating potential for upside to conservative revenue forecasts. Operating leverage is beginning to emerge with operating income growth of 14.4% exceeding revenue growth, though the 3.9% operating margin remains structurally low at less than half the 8.3% industry median, requiring sustained margin expansion initiatives to reach competitive profitability levels. Working capital efficiency deterioration represents a critical near-term focus area, with 138-day DSO exceeding industry median by 55 days and implying approximately 2.1 billion yen of excess receivables tied up compared to peer collection speeds, alongside elevated work-in-process inventory suggesting production process optimization opportunities. The 63.5% increase in investment securities to 2.09 billion yen introduces portfolio diversification but also fair value volatility risk, with the strategic rationale for this capital allocation requiring monitoring versus reinvestment in core business margin improvement or working capital reduction that could drive higher ROIC.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.